Derek Lowe, an Arkansan by birth, got his BA from Hendrix College and his PhD in organic chemistry from Duke before spending time in Germany on a Humboldt Fellowship on his post-doc. He's worked for several major pharmaceutical companies since 1989 on drug discovery projects against schizophrenia, Alzheimer's, diabetes, osteoporosis and other diseases.
To contact Derek email him directly: derekb.lowe@gmail.com
Twitter: Dereklowe
Well, Carl Icahn may well be through messing with the biotech industry, as speculated earlier this year. His chief biotech strategist has now left his employ - but looks to be starting his own hedge fund. So look out for Alex Denner, folks, because he might just be ready to continue the tradition.
1. Student on November 15, 2011 6:26 PM writes...
I don't know anything about this guy. Do you know of any writeups about him? I'm curious if his having a PhD has helped him make better decisions.
Permalink to Comment2. James Hetfield on November 16, 2011 1:05 PM writes...
Actually it's "Exit light, enter night"
Permalink to Comment